KLEx
Cross-source consensus on KLEx from 1 sources and 4 claims.
1 sources · 4 claims
Uses
How it works
Benefits
Background
Highlighted claims
- KLEx corrects refractive error by extracting an intrastromal lenticule through a small incision without creating a flap. — Keratorefractive lenticule extraction (KLEx) versus femtosecond laser-assisted in situ keratomileusis (FS-LASIK) for the treatment of myopia and compound myopic astigmatism: study protocol of a randomised clinical trial in Mexico
- The trial evaluates KLEx using the Schwind SmartSight system on the ATOS femtosecond laser. — Keratorefractive lenticule extraction (KLEx) versus femtosecond laser-assisted in situ keratomileusis (FS-LASIK) for the treatment of myopia and compound myopic astigmatism: study protocol of a randomised clinical trial in Mexico
- KLEx was formerly known as SMILE and received FDA approval for myopia and later myopic astigmatism. — Keratorefractive lenticule extraction (KLEx) versus femtosecond laser-assisted in situ keratomileusis (FS-LASIK) for the treatment of myopia and compound myopic astigmatism: study protocol of a randomised clinical trial in Mexico
- KLEx is expected to avoid flap-related complications and may reduce postoperative dry eye by preserving corneal innervation more effectively. — Keratorefractive lenticule extraction (KLEx) versus femtosecond laser-assisted in situ keratomileusis (FS-LASIK) for the treatment of myopia and compound myopic astigmatism: study protocol of a randomised clinical trial in Mexico